Clinical Trial Update: A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind trial comparing Micardis Plus (telmisartan/hydrochlorothiazide) with Hyzaar (losartan/hydrochlorothiazide) in Taiwanese patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Hyzaar (losartan/hydrochlorothiazide)
• Micardis Plus (telmisartan/hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED